Fort Pitt Capital Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Fort Pitt Capital Group's NVS Position: Q3 2024 in Review
Fort Pitt Capital Group increased its Novartis (NVS) stake by 2.7% in Q3 2024, buying an estimated $102K and bringing the position to 33,709 shares worth $3.88M. The position accounts for 0.11% of the portfolio, ranked #56.
Fort Pitt Capital Group first reported a position in NVS in Q1 2018 and has held it in 17 quarters since. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.
- Fort Pitt Capital Group held 33,709 shares of Novartis worth $3.88M as of Q3 2024.
- Fort Pitt Capital Group bought 899 Novartis shares in Q3 2024, an estimated $102K.
- Novartis made up 0.11% of Fort Pitt Capital Group's portfolio in Q3 2024, its #56 holding.
- Fort Pitt Capital Group first reported a position in Novartis in Q1 2018 and has held it in 17 quarters since.
- 1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.
Based on Fort Pitt Capital Group's 13F filing for Q3 2024, filed 29 Oct 2024.